Clinical Trial Update: Effects of Hemofiltration and Mannitol Treatment on Cardiopulmonary-Bypass Induced Immunosuppression [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update examines whether hemofiltration and mannitol can influence cardiopulmonary bypass–induced immunosuppression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation

Drugs mentioned

• Mannitol (mannitol)

Snippet

Sponsor: University Hospital, Saarland | Conditions: Inflammation | Phase 4 | Status: UNKNOWN